OncoQuest Pharmaceuticals Inc (078590) - Total Assets
Based on the latest financial reports, OncoQuest Pharmaceuticals Inc (078590) holds total assets worth ₩94.30 Billion KRW (≈ $63.91 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
OncoQuest Pharmaceuticals Inc - Total Assets Trend (2014–2025)
This chart illustrates how OncoQuest Pharmaceuticals Inc's total assets have evolved over time, based on quarterly financial data. Also see 078590 company net worth for the company's overall valuation and market capitalisation.
OncoQuest Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
OncoQuest Pharmaceuticals Inc's total assets of ₩94.30 Billion consist of 22.5% current assets and 77.5% non-current assets. Review OncoQuest Pharmaceuticals Inc (078590) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 3.9% |
| Accounts Receivable | ₩2.71 Billion | 3.3% |
| Inventory | ₩500.06 Million | 0.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩1.56 Billion | 1.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how OncoQuest Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See OncoQuest Pharmaceuticals Inc (078590) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OncoQuest Pharmaceuticals Inc's current assets represent 22.5% of total assets in 2025, a decrease from 50.2% in 2014.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2025, down from 8.7% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 4.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 3.3% of total assets.
OncoQuest Pharmaceuticals Inc Competitors by Total Assets
Key competitors of OncoQuest Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
OncoQuest Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.61 | 0.68 | 3.55 |
| Quick Ratio | 1.58 | 0.66 | 3.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩11.42 Billion | ₩-8.52 Billion | ₩14.27 Billion |
OncoQuest Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between OncoQuest Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.30 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.4% |
| Total Assets | ₩81.61 Billion |
| Market Capitalization | $106.61 Million USD |
Valuation Analysis
Below Book Valuation: The market values OncoQuest Pharmaceuticals Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: OncoQuest Pharmaceuticals Inc's assets grew by 8.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for OncoQuest Pharmaceuticals Inc (2014–2025)
The table below shows the annual total assets of OncoQuest Pharmaceuticals Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩81.61 Billion ≈ $55.30 Million |
+8.36% |
| 2024-12-31 | ₩75.31 Billion ≈ $51.04 Million |
+38.97% |
| 2023-12-31 | ₩54.19 Billion ≈ $36.73 Million |
+23.10% |
| 2022-12-31 | ₩44.02 Billion ≈ $29.83 Million |
-38.78% |
| 2019-12-31 | ₩71.91 Billion ≈ $48.73 Million |
+2.61% |
| 2018-12-31 | ₩70.09 Billion ≈ $47.50 Million |
+154.58% |
| 2017-12-31 | ₩27.53 Billion ≈ $18.66 Million |
+27.73% |
| 2016-12-31 | ₩21.55 Billion ≈ $14.61 Million |
+14.19% |
| 2015-12-31 | ₩18.88 Billion ≈ $12.79 Million |
+12.97% |
| 2014-12-31 | ₩16.71 Billion ≈ $11.32 Million |
-- |
About OncoQuest Pharmaceuticals Inc
DIAC Co., Ltd. engages in the car interior and exterior materials business in South Korea and internationally. DIAC Co., Ltd. was founded in 1993 and is headquartered in Miryang-si, South Korea.